Rocket Pharmaceuticals, Inc.

NASDAQ:RCKT

Biotechnology

Healthcare
$2.11 +1.84%

+$0.06 today

Market cap
$235.60M
Beta
0.47
P/E (TTM)
-1.7
EPS (TTM)
-$1.87
52W Low $2.40High $5.45

Volume 2.49M

Average 3.15M

Balance Sheet

Inspect the capital base behind the business.

Assets

$330.45M

FY 2025 · Annual

-37.4% YoY

Liabilities

$53.23M

FY 2025 · Annual

-17.4% YoY

Equity

$277.22M

FY 2025 · Annual

-40.2% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents232.69M140.52M55.9M163.64M77.56M
Short-term Investments156.05M215.88M317.27M208.7M111.37M
Net Receivables00000
Inventory00000
Other Current Assets07.67M5.05M5.85M3.81M
Total Current Assets392.06M364.06M378.22M378.18M192.73M
Property, Plant & Equipment (Net)72.35M77.65M87.59M83.32M71.59M
Goodwill30.82M39.15M39.15M39.15M39.15M
Intangible Assets025.72M25.15M25.15M25.15M
Long-term Investments043.28M34.32M01.34M
Tax Assets00000
Other Non-current Assets1.8M1.95M1.91M1.89M482K
Total Non-current Assets104.96M187.75M188.12M149.52M137.72M
Total Assets497.02M551.81M566.34M527.7M330.45M
Account Payables0001.63M0
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities4.53M10.01M9.93M185K12.29M
Total Current Liabilities22.17M39.17M48.51M40.68M30.21M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities80K2.6M2.94M1.14M1.06M
Total Non-current Liabilities20.13M22.95M25.26M23.78M23.02M
Total Liabilities42.3M62.12M73.77M64.47M53.23M
Common Stock645K791K903K1.07M1.08M
Retained Earnings(491.91M)(713.78M)(959.37M)(1.22B)(1.44B)
Accumulated OCI(161K)(357K)319K66K(31K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity454.72M489.69M492.57M463.23M277.22M
Total Debt22.6M22.87M25.04M25.5M24.88M
Net Debt(210.09M)(117.65M)(30.86M)(138.14M)(52.68M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$49.6M
Short-term Investments$94.8M
Other Current$5.4M
Total Current Assets$149.8M
PP&E (Net)$69.5M
Goodwill$39.2M
Intangible Assets$25.1M
Long-term Investments$1.3M
Other Non-current$482.0K
Total Non-current Assets$135.6M
Total Assets$285.4M

Analysis

Selected assets total $285.4M for Latest. The largest visible component is Short-term Investments at $94.8M, about 33.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 12, 2026
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
4Statement of changes in beneficial ownershipNov 9, 2026
SC 13G/ASC 13G/A filingOct 30, 2026

How much cash does RCKT have?

Rocket Pharmaceuticals, Inc. (RCKT) reported $77.56M in cash and equivalents in fiscal 2025.

How much debt does RCKT carry?

Rocket Pharmaceuticals, Inc. (RCKT) reported $24.88M of total debt, with net debt of -$52.68M.